Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA 4.45EWJ 2.89TECK.B.TO 5.26CNQ.TO -0.07HHL.TO 0.035SYLD 1.14HAC.TO 0.14TRU -2.15
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
HOLD

Pfizer Inc(PFE)

Jul 02, 2003
If you own it, don't let it make new lows on you. Trend is moving higher.
Photo of Bill CarriganBill CarriganUnlock Rating
$34.65

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 19, 2003
All drug companies offer good value right now. Prefers Bristol Myers Squibb.
Photo of Ray SteeleRay SteeleUnlock Rating
$35.60

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Jun 13, 2003
US is making progress on a medicare drug plan. 17 X this years earnings and 16 X next. Great pipeline. The stock has underperformed.A lot of free cash flow.
Photo of Laura WallaceLaura WallaceUnlock Rating
$33.08

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 11, 2003
US pharmaceuticals are looking cheaper than they have in some time.
Photo of John ZechnerJohn ZechnerUnlock Rating
$33.28

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Jun 05, 2003
(Was a top pick on Sept 18/02. Up 10%.) Still likes. Thought they would have been higher. Have the most new products coming on line.
Photo of Rob CallanderRob CallanderUnlock Rating
$32.75

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

May 30, 2003
Has been stuck under a major technical resistance of $33/34. Could have a drop.
Photo of Ross HealyRoss HealyUnlock Rating
$31.02

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

May 21, 2003
(Was a top pick on Apr 16/03. Not much change.) Still likes. Continuing to buy at this price.
Photo of Laura WallaceLaura WallaceUnlock Rating
$31.50

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

May 14, 2003
(Was a top pick on Mar 31/03. Up 6.8%) Still likes. Merger with Pharmacia gives them a very powerful potent drug patent.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$33.21

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Apr 30, 2003
Questioner: "Why is it stuck in a $30/31 range?" Response: "Likes at this price. Their drugs and pipeline are good. Has a lot of cash."
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$30.75

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Apr 22, 2003
A favourite drug stock in their funds. Earnings growth should be 15% over the next several years. Dividend yield is decent. Has a very good pipeline of drugs.
Photo of Brad WillockBrad WillockUnlock Rating
$31.82

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Apr 16, 2003
Just completed a good merger with Pharmacia. Good pipeline.
Photo of Laura WallaceLaura WallaceUnlock Rating
$31.36

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Mar 31, 2003
Just got approval on new products and should move up.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$31.16

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Mar 24, 2003
More expensive in the drug sector. Merk is a better buy.
Photo of Peter Arender, CFAPeter Arender, CFAUnlock Rating
$30.99

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Feb 06, 2003
Pretty good value. The merger will allow some cost cutting. A good price.
Photo of Ray SteeleRay SteeleUnlock Rating
$29.78

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Feb 04, 2003
Photo of Peter Arender, CFAPeter Arender, CFAUnlock Rating
$29.84

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
Showing 691 to 705 of 801 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV -2.21$161.55
WSP.TO 0.31$183.77
VRTX 9.33$445.04
OTEX.TO 0.24$30.52
CCO.TO 5.6$138.04
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

NVDA 4.45$204.87
EWJ 2.89$92.18
TECK.B.T… 5.26$88.81
CNQ.TO -0.07$63.52
HHL.TO 0.035$6.945

Popular Articles

Latest Sell Signals

TD.TO 2.57$162.22
MBLY 0.44$9.58
ASAN -0.12$7.46
MODG 0.53$16.79
NVTS 1.71$22.21

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video